respiratori
disord
lead
caus
death
person
acut
chronic
spinal
cord
injuri
sci
pneumonia
occur
patient
acut
tetraplegia
acut
hospit
rehabilit
respiratori
disord
account
death
first
year
injuri
death
later
year
patient
surviv
least
hour
injuri
pneumonia
influenza
caus
death
contrast
gener
popul
unit
state
pneumonia
influenza
account
death
two
diseas
combin
eighth
lead
caus
death
standard
mortal
ratio
measur
adjust
age
sex
race
indic
rate
fatal
pneumonia
elev
factor
peopl
sci
person
complet
tetraplegia
die
pneumonia
rate
time
higher
match
popul
without
sci
respiratori
disord
also
lead
caus
rehospit
sci
base
unit
state
us
model
sci
system
msci
data
third
common
reason
hospit
first
year
sci
populationbas
studi
alberta
canada
found
respiratori
complic
lead
caus
rehospit
first
year
injuri
patient
american
spinal
injuri
associ
asia
impair
scale
ac
tetraplegia
account
rehopit
across
year
followup
spite
import
respiratori
infect
caus
death
person
sci
studi
examin
topic
major
report
incid
respiratori
complic
acut
care
rehabilit
set
msci
hospit
rehospit
rate
caus
death
person
chronic
sci
also
publish
use
data
us
msci
well
nation
recent
data
outpati
respiratori
infect
veteran
affair
va
patient
sci
report
popul
includ
studi
may
repres
person
sci
focus
epidemiolog
aspect
respiratori
infect
remain
need
conduct
clinic
trial
prevent
measur
treatment
reduc
morbid
mortal
associ
respiratori
infect
popul
predispos
factor
person
spinal
cord
injuri
sci
caus
multipl
alter
normal
physiolog
may
increas
likelihood
develop
respiratori
infect
incid
increas
chanc
die
infect
case
fatal
obviou
dysfunct
caus
sci
weak
respiratori
muscl
neurolog
level
rostral
may
degre
diaphragm
weak
even
complet
paralysi
higher
level
motorcomplet
injuri
lower
neurolog
level
diaphragm
innerv
intact
normal
suffici
maintain
least
predict
vital
capac
ventilatori
failur
caus
inspiratori
muscl
weak
occur
immedi
injuri
develop
first
week
injuri
patient
requir
mechan
ventil
suscept
ventilatorassoci
pneumonia
vap
first
week
month
injuri
mani
patient
partial
intact
diaphragm
innerv
acquir
abil
spontan
ventil
part
caus
strength
recoveri
diaphragm
approxim
person
sci
ventil
depend
discharg
rehabilit
patient
reduc
inspiratori
muscl
strength
predispos
microatelectasi
may
promot
develop
pneumonia
atelectat
segment
lung
sever
expiratori
muscl
weak
preval
person
sci
like
import
factor
increas
incid
case
fatal
pneumonia
expiratori
muscl
weak
result
low
voluntari
cough
peak
expiratori
flow
strongli
associ
unsuccess
extub
increas
inhospit
mortal
gener
popul
primari
expiratori
muscl
intern
intercost
abdomin
thorac
innerv
paralyz
complet
patient
motorcomplet
tetraplegia
expiratori
strength
increas
increment
addit
neurolog
level
essenti
normal
neurolog
level
therefor
patient
highlevel
paraplegia
similar
degre
weak
lowlevel
tetraplegia
main
consequ
expiratori
muscl
weak
reduc
peak
cough
flow
ineffect
clearanc
bronchial
secret
peak
cough
flow
less
lsec
lmin
inadequ
airflow
mobil
secret
bronchi
trachea
compens
weak
cough
strength
aggress
multimod
respiratori
therapi
intervent
requir
secret
mobil
measur
promot
secret
mobil
list
tabl
respiratori
muscl
weak
addit
factor
predispos
patient
respiratori
complic
reduc
sympathet
innerv
lung
occur
injuri
midthorac
level
unoppos
vagal
parasympathet
input
patient
tetraplegia
lead
bronchoconstrict
increas
bronchial
mucu
secret
patient
acut
tetraplegia
bronchial
mucu
product
may
exceed
l
per
day
secret
often
tenaci
like
alter
tabl
secret
mobil
techniqu
manuallyassist
cough
quad
cough
b
insuffl
use
bagvalvemask
eg
ambubag
glossopharyng
breath
quad
cough
increas
peak
cough
flow
aspir
rel
common
patient
acut
tetraplegia
especi
predispos
factor
mechan
ventil
tracheostomi
anterior
neck
surgeri
brain
injuri
autonom
mediat
dynam
dysfunct
pharynx
upper
esophag
sphincter
may
addit
contribut
factor
patient
chronic
sci
normal
bacteri
flora
alter
number
reason
includ
frequent
treatment
antibiot
autonom
mediat
chang
skin
resid
health
care
set
result
increas
colon
gramneg
antibioticresist
organ
subclin
adren
insuffici
common
popul
may
blunt
respons
sepsi
infect
present
diminish
immun
respons
person
tetraplegia
also
describ
could
increas
suscept
infect
howev
antibodi
respons
pneumococc
influenza
vaccin
person
sci
similar
gener
popul
pneumonia
acut
infect
pulmonari
parenchyma
diagnos
presenc
symptom
either
infiltr
chest
radiograph
examin
find
indic
consolid
common
wide
studi
epidemiolog
categori
pneumonia
term
communityacquir
pneumonia
cap
common
cap
pathogen
overal
well
fatal
case
alon
streptococcu
pneumonia
pneumococcu
common
pathogen
includ
hemophilu
influenza
mycoplasma
pneumonia
chlamydophila
pneumonia
common
risk
factor
cap
includ
young
advanc
age
medic
comorbid
includ
chronic
lung
diseas
smoke
immunosuppress
alcohol
use
gastric
acidsuppress
drug
proton
pump
inhibitor
blocker
also
appear
risk
factor
cap
chest
radiographi
primari
test
establish
diagnosi
cap
distinguish
acut
bronchiti
patient
hospit
recommend
also
follow
test
complet
blood
count
differenti
serum
chemistri
panel
liver
function
test
oxygen
satur
blood
cultur
sputum
gram
stain
cultur
also
recommend
util
debat
goodqual
sputum
predomin
organ
obtain
patient
howev
presenc
gramposit
diplococci
gram
stain
highli
specif
pneumococcu
case
fatal
cap
vari
wide
across
studi
vari
patient
popul
populationbas
data
patient
receiv
care
set
inpati
outpati
indic
mortal
rate
wherea
cohort
studi
indic
mortal
rate
pneumonia
patient
outcom
research
team
pneumonia
port
deriv
algorithm
determin
whether
adult
cap
hospit
treat
commun
base
shortterm
mortal
risk
patient
stratifi
five
sever
class
outpati
treatment
gener
recommend
two
lowest
risk
class
qualifi
lowest
risk
class
adult
would
age
year
less
none
import
comorbid
cancer
liver
diseas
congest
heart
failur
renal
diseas
cerebrovascular
diseas
normal
mental
statu
normal
mildli
abnorm
vital
sign
patient
two
lowest
risk
categori
anticip
shortterm
mortal
risk
less
rule
meant
supersed
clinic
judgment
take
account
reason
hospit
besid
predict
risk
death
pneumonia
could
includ
risk
advers
event
avail
support
home
likelihood
adher
therapi
followup
recommend
recent
recogn
specif
outpati
popul
pneumonia
increas
risk
highli
resist
bacteri
pathogen
occur
hospit
patient
case
pneumonia
correctli
defin
health
careassoci
pneumonia
hcap
rather
cap
risk
factor
hcap
includ
follow
day
acut
care
hospit
prior
day
antibiot
therapi
chemotherapi
wound
care
prior
day
resid
nurs
home
longterm
care
facil
hemodialysi
hospit
clinic
etiolog
pathogen
popul
well
treatment
principl
thought
similar
hospitalacquir
pneumonia
hap
see
excess
mortal
caus
acut
condit
specif
popul
pneumonia
person
sci
attribut
increas
incid
disord
increas
case
fatal
disord
develop
combin
factor
limit
evid
support
increas
incid
increas
case
fatal
pneumonia
person
chronic
sci
primari
evid
come
epidemiolog
studi
use
va
administr
data
person
sci
smith
colleagu
determin
outpati
visit
rate
acut
respiratori
infect
includ
pneumonia
base
administr
data
respiratoryrel
visit
popul
veteran
sci
annual
outpati
visit
either
pneumonia
influenza
nearli
pneumonia
averag
per
veteran
smaller
populationbas
studi
alberta
canada
report
similar
rate
episod
pneumonia
per
patient
per
year
first
year
injuri
compar
data
overal
us
popul
indic
rate
case
pneumonia
per
patient
per
year
use
va
administr
data
studi
weaver
colleagu
outcom
pneumonia
estim
determin
hospit
rate
allcaus
mortal
within
day
visit
outpati
visit
pneumonia
patient
hospit
day
overal
patient
die
within
day
outpati
visit
comparison
roughli
gener
popul
pneumonia
hospit
manag
va
studi
use
administr
data
link
pneumonia
diagnosi
subsequ
death
clearli
establish
howev
case
fatal
appear
much
higher
previous
cite
case
fatal
seen
gener
popul
etiolog
pathogen
cap
also
examin
use
va
administr
data
sci
veteran
hospit
treatment
cap
period
author
also
determin
whether
identif
caus
pathogen
cap
associ
outcom
person
sci
case
identifi
cap
hospit
admiss
preced
immedi
outpati
care
diagnost
code
pneumonia
signific
associ
found
identif
specif
pathogen
mortal
hospit
sci
patient
cap
mean
length
stay
day
overal
case
fatal
studi
caus
pathogen
identifi
case
pneumococcu
lead
caus
pneumonia
case
true
gener
popul
cap
pseudomona
uncommon
pathogen
cap
gener
popul
second
commonli
identifi
pathogen
occur
case
find
prompt
clinician
consid
whether
patient
pneumonia
risk
factor
hcap
rather
cap
pseudomona
colon
perineum
lower
urinari
tract
urin
collect
system
common
person
sci
may
risk
factor
pseudomona
pneumonia
popul
wellrecogn
risk
factor
gramneg
pneumonia
antibiot
treatment
hospit
prior
day
pulmonari
comorbid
aspir
rel
common
popul
well
gener
popul
rel
risk
death
elev
factor
pseudomona
pneumonia
compar
pathogen
addit
va
studi
character
clinic
manag
cap
three
va
hospit
special
sci
servic
use
abstract
individu
electron
medic
record
sci
veteran
receiv
outpati
inpati
treatment
cap
studi
period
case
identifi
initi
va
administr
databas
use
method
use
chang
coauthor
addit
case
sole
receiv
outpati
diagnosi
pneumonia
requir
hospit
medic
record
review
confirm
diagnosi
cap
detail
inform
clinic
present
diagnost
evalu
treatment
abstract
record
patient
hospit
treat
outpati
patient
treat
hospit
special
sci
servic
may
indic
sci
specialist
like
recommend
admiss
treatment
hap
mean
length
stay
hospit
patient
day
antibiot
coverag
receiv
accord
recommend
infecti
diseas
societi
america
one
half
patient
account
rel
high
rate
fluoroquinolon
resist
particip
institut
patient
receiv
reliabl
antipseudomon
coverag
inhospit
mortal
rate
year
followup
hospit
survivor
die
gener
popul
studi
use
develop
cap
treatment
algorithm
involv
decis
whether
hospit
patient
choic
empir
antibiot
coverag
common
pathogen
unfortun
clear
principl
may
directli
appli
popul
sci
resid
commun
exampl
pneumonia
port
algorithm
assign
increas
risk
either
expiratori
dysfunct
margin
ventilatori
statu
may
present
sci
use
recommend
person
sci
like
underestim
mortal
risk
recommend
manag
cap
person
sci
summar
tabl
tabl
recommend
manag
cap
person
sci
hospit
versu
outpati
treatment
criteria
deriv
nonsci
popul
pneumonia
port
may
accur
predict
mortal
person
sci
hospit
strongli
encourag
high
case
fatal
likelihood
resist
organ
possibl
inadequ
secret
mobil
consid
assist
avail
home
skill
patient
caregiv
secret
mobil
likelihood
complianc
therapi
avail
access
followup
care
optim
secret
mobil
multimod
treatment
quad
cough
manual
assist
cough
may
preced
insuffl
mechan
insufflatorexsuffl
coughassist
sputum
gram
stain
cultur
low
diagnost
yield
strongli
consid
could
identifi
unsuspect
highli
resist
organ
low
virul
organ
identifi
antibiot
spectrum
may
narrow
avoid
promot
antibiot
resist
antibiot
evalu
risk
factor
resist
organ
consid
hcap
consid
empir
antipseudomon
coverag
prompt
administr
antibiot
given
high
incid
case
fatal
seen
pneumonia
outpati
sci
import
seemingli
benign
selflimit
condit
viral
upper
respiratori
infect
uri
acut
bronchiti
self
evid
categori
respiratori
infect
exceedingli
common
gener
popul
although
frequent
present
primari
care
set
evalu
caus
much
absente
work
school
gener
recogn
caus
morbid
mortal
except
epidem
influenza
howev
viral
respiratori
infect
commonli
preced
precipit
hospit
especi
patient
chronic
underli
pulmonari
condit
nearli
patient
hospit
acut
respiratori
condit
evid
recent
respiratori
tract
viral
infect
virus
includ
commonli
associ
sever
respiratori
infect
influenza
respiratori
syncyti
viru
also
associ
common
cold
rhinovirus
coronavirus
ventilatordepend
patient
neuromuscular
disord
pneumonia
hospit
preced
upper
respiratori
tract
infect
upper
respiratori
infect
primarili
viral
etiolog
approxim
pharyng
case
involv
group
streptococcu
inflammatori
respons
initi
local
primari
level
respiratori
tract
case
spread
adjac
deeper
portion
well
involv
trachea
cough
sputum
product
signific
symptom
may
last
week
acut
bronchiti
indic
acut
respiratori
infect
involv
lower
portion
respiratori
tract
cough
predomin
featur
without
sputum
product
incid
acut
bronchiti
gener
popul
seek
medic
attent
without
underli
medic
condit
disord
usual
selflimit
almost
associ
mortal
key
compon
evalu
rule
seriou
condit
pneumonia
case
caus
nonbacteri
pathogen
routin
antibiot
treatment
recommend
limit
data
support
increas
mortal
patient
sci
acut
bronchiti
base
va
administr
data
veteran
sci
evalu
outpati
set
rate
visit
per
year
per
veteran
lower
respiratori
infect
acut
bronchiti
visit
per
year
per
veteran
upper
respiratori
infect
mortal
rate
day
visit
acut
bronchiti
upper
respiratori
tract
infect
patient
seen
acut
bronchiti
hospit
day
outpati
visit
howev
requir
hospit
subsequ
day
find
indic
person
sci
acut
bronchiti
associ
small
increas
mortal
hospit
rel
common
outpati
evalu
bronchiti
studi
design
preclud
determin
whether
pneumonia
misdiagnos
acut
bronchiti
patient
whether
pneumonia
subsequ
develop
consequ
retain
excess
bronchial
secret
although
respiratori
infect
import
sourc
morbid
mortal
person
sci
challeng
conduct
prospect
research
prevent
strategi
lack
research
popul
recommend
prevent
primarili
deriv
patient
popul
knowledg
pathophysiolog
alter
follow
sci
clinic
experi
manag
patient
high
risk
sever
respiratori
infect
influenza
vaccin
reduc
influenzarel
hospit
death
secondari
complic
elderli
patient
without
highrisk
medic
condit
diabet
current
center
diseas
control
prevent
cdc
recommend
annual
influenza
vaccin
group
risk
sever
complic
influenza
includ
chronic
pulmonari
vascular
diseas
resid
chronic
care
facil
cdc
extend
recommend
includ
children
adult
sci
pneumococcu
lead
caus
cap
gener
popul
person
sci
pneumococc
polysaccharid
vaccin
shown
reduc
risk
invas
ie
bacterem
pneumococc
diseas
consid
cost
effect
elderli
person
also
recommend
person
age
year
older
chronic
ill
includ
pulmonari
diseas
base
recommend
routin
offer
person
sci
major
degre
respiratori
impair
howev
minor
pneumococc
pneumonia
result
bacteremia
vaccin
found
effect
noninvas
diseas
elderli
patient
rate
cap
pneumonia
hospit
unaffect
pneumococc
vaccin
aggress
mobil
secret
could
play
import
role
reduc
respiratori
infect
outpati
sci
small
proport
patient
primarili
cervic
level
injuri
appear
benefit
routin
bronchial
secret
clearanc
even
absenc
acut
respiratori
infect
typic
achiev
use
quad
cough
mechan
insufflationexsuffl
daili
basi
commonli
assist
secret
mobil
becom
necessari
respiratori
infect
develop
note
earlier
viral
upper
respiratori
infect
acut
bronchiti
may
lead
subsequ
develop
pneumonia
prompt
clearanc
bronchial
secret
may
prevent
format
microatelectasi
increas
bacteri
load
lower
respiratori
tract
develop
pneumonia
hospitalacquir
pneumonia
gener
popul
hap
defin
pneumonia
occur
hour
hospit
admiss
incub
time
admiss
rate
hap
gener
popul
per
hospit
admiss
lead
caus
death
hospitalacquir
infect
find
hap
deriv
patient
ventilatorassoci
pneumonia
vap
risk
pneumonia
time
greater
nonventil
patient
risk
factor
hap
gener
popul
includ
prolong
hospit
malnutrit
respiratori
failur
sedat
medic
dysphagia
central
nervou
system
disord
supin
posit
feed
chronic
obstruct
pulmonari
diseas
prolong
use
antibiot
case
fatal
rate
hap
may
high
certain
subpopul
mechan
ventil
patient
although
one
third
one
half
death
directli
attribut
infect
common
hap
pathogen
includ
aerob
gramneg
rod
pseudomona
aeruginosa
escherichia
coli
klebsiella
acinetobact
well
gramposit
cocci
increas
rate
methicillinresist
staphylococcu
aureu
spectrum
pathogen
similar
elderli
resid
longterm
care
facil
hcap
sourc
multidrugresist
pathogen
includ
health
care
devic
especi
respiratori
care
equip
fomit
hospit
environ
patient
pathogen
transfer
patient
routin
care
bacteria
may
reach
lower
respiratori
tract
gross
microscop
aspir
inhal
direct
inocul
respiratori
care
equip
guidelin
manag
prevent
hap
publish
american
thorac
societi
infecti
diseas
societi
america
center
diseas
control
prevent
select
recommend
document
summar
tabl
note
earlier
etiolog
pathogen
hcap
similar
hap
hap
manag
principl
thought
appli
hcap
well
respiratori
complic
includ
pneumonia
common
acut
care
initi
rehabilit
sci
occurr
close
associ
acut
care
length
stay
hospit
cost
person
new
tetraplegia
import
determin
cost
injuri
level
publish
find
pneumonia
person
sci
come
patient
undergo
acut
care
initi
rehabilit
msci
hospit
jackson
groom
found
rate
pneumonia
acut
care
rehabilit
fishburn
colleagu
report
combin
rate
pneumonia
atelectasi
first
month
injuri
rate
patient
highlevel
tetraplegia
receiv
inpati
rehabilit
acut
care
patient
complet
tetraplegia
atelectasi
pneumonia
note
pneumonia
develop
soon
injuri
left
side
attribut
difficulti
clear
secret
left
bronchial
tree
use
tracheal
suction
acut
takeoff
angl
left
mainstem
bronchu
publish
data
etiolog
organ
pneumonia
develop
acut
care
initi
rehabilit
phase
person
sci
patient
like
similar
risk
hospit
patient
colon
multidrugresist
bacteria
day
hospit
therefor
choic
empir
antibiot
coverag
ident
hap
neurolog
intact
patient
base
part
durat
hospit
high
incid
case
fatal
cap
like
primari
reason
pneumonia
lead
caus
death
sci
howev
hap
could
potenti
account
substanti
proport
pneumoniarel
death
person
chronic
sci
date
studi
examin
epidemiolog
pathogen
risk
factor
hap
chronic
injur
popul
mani
risk
factor
hap
gener
popul
preval
hospit
person
chronic
sci
includ
expiratori
dysfunct
prolong
antibiot
treatment
sedat
medic
supin
posit
feed
respiratori
infect
common
person
sci
pneumonia
lesser
degre
acut
bronchiti
associ
signific
morbid
mortal
guidelin
treatment
cap
develop
use
gener
popul
may
appropri
person
sci
optim
manag
respiratori
infect
must
take
account
sever
expiratori
dysfunct
highli
preval
popul
well
risk
factor
hcap
outpati
pneumonia
person
sci
inform
risk
respiratori
infect
encourag
seek
prompt
evalu
physician
knowledg
complic
sci
